U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H16O2
Molecular Weight 192.2542
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of IBUFENAC

SMILES

CC(C)CC1=CC=C(CC(O)=O)C=C1

InChI

InChIKey=CYWFCPPBTWOZSF-UHFFFAOYSA-N
InChI=1S/C12H16O2/c1-9(2)7-10-3-5-11(6-4-10)8-12(13)14/h3-6,9H,7-8H2,1-2H3,(H,13,14)

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/14261081

Ibufenac was used as an analgesic and anti-inflammatory agent, but was withdrawn from the market due to hepatotoxicity.

Originator

Boots Pure Drug Company
1
Curator's Comment: Adams, Cliffe, Lessel, and Nicholson (1963) from the Research Laboratories of Boots Pure Drug Company, Nottingham, reported the biological properties of a new substance, 4-isobutylphenyl acetic acid (Ibufenac).

Approval Year

Unknown
139594
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Withdrawn
Dytransin

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience.
2006 Apr
Patents

Patents

JP2006524634A
46
JPS5253833A
1

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Most patients received 2 to 4 weeks' therapy but in certain instances long-term treatment was continued.
The daily dose varied between 6 and 15 tablets each containing 250 mg.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
IBUFENAC
INN   JAN   MART.   MI   USAN   WHO-DD  
USAN   INN  
Official Name English
RD-11654
Code English
IBUFENAC [USAN]
Common Name English
IBUFENAC [JAN]
Common Name English
BENZENEACETIC ACID, 4-(2-METHYLPROPYL)-
Common Name English
(P-ISOBUTYLPHENYL)ACETIC ACID
Common Name English
IBUFENAC [MART.]
Common Name English
ibufenac [INN]
Common Name English
IBUFENAC [MI]
Common Name English
NSC-99976
Code English
RD 11654
Code English
Ibufenac [WHO-DD]
Common Name English
DYTRANSIN
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C257
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
Code System Code Type Description
EVMPD
SUB08097MIG
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
FDA UNII
5V4WIX44VI
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
DRUG CENTRAL
3293
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
CAS
1553-60-2
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
NCI_THESAURUS
C96750
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
PUBCHEM
15250
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
ECHA (EC/EINECS)
216-302-2
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
INN
1649
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
SMS_ID
100000083648
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
MESH
C100118
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
NSC
99976
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
EPA CompTox
DTXSID0044107
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
MERCK INDEX
m1190
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY Merck Index
CHEBI
76158
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
ChEMBL
CHEMBL341812
Created by admin on Fri Dec 15 14:59:10 GMT 2023 , Edited by admin on Fri Dec 15 14:59:10 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of IBUFENAC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966